2016 American Transplant Congress
Socioeconomic Status and Readmission Following Kidney Transplant.
Transplant Surgery, Johns Hopkins Hospital, Baltimore.
Our group has previously demonstrated that 31% of kidney transplant recipients are readmitted within 30 days of discharge from the original hospitalization. Patient-level contributors such…2016 American Transplant Congress
Virological Profile of Deceased Organ Donors in the UK.
Background: To date there has been no routine surveillance of infections in deceased solid organ donors in the UK. A national scheme to monitor infectious…2016 American Transplant Congress
Review of Organ Utilization from Increased Infectious Risk Donors.
IntroductionDonors with an increased risk of transmitting HIV, HBV or HCV (IRDs) are a potential source of organs. There is a lack of data on…2016 American Transplant Congress
Impact on Wound Healing Events After Early Conversion to Everolimus in De Novo Renal Transplant Recipients: 24-Month Results from the Randomized ELEVATE Study.
BackgroundWound healing events (WHE) are probably the most common type of post-transplant (Tx) surgical complication. Due to its antiproliferative properties, mammalian target of rapamycin inhibitors…2016 American Transplant Congress
Safety, Efficacy, and Cost Saving Potential of Various Weight-Based Dosing for Thymoglobulin Induction Therapy in Kidney Transplant Recipients.
Introduction: There are limited data assessing the appropriate weight to use when dosing Thymoglobulin for induction therapy. The aim of this study is to assess…2015 American Transplant Congress
Systematic Medical Record Review to Identify Safety Risks in Living Liver Donors
BACKGROUNDPrevention of adverse events (AEs) is important in Living Donor Liver Transplantation (LDLT), as these are healthy volunteers who undergo a major procedure with no…2015 American Transplant Congress
Somatostatin (Eumedica®) Infusion Allows Modulating Graft Flows and Gradients in Liver Transplantation. Results of a Randomized, Double Blind, Placebo Controlled Trial
Background: Somatostatin (SST) infusion decrease portal pressure in acute variceal bleeding in cirrhotic patients. Despite liver transplantation (LTx), recipients with portal hypertension (PHT) display different…2015 American Transplant Congress
Belatacept in a Community Hospital Adult Kidney Transplant Program
Iowa Methodist Medical Center, Des Moines, IA.
PURPOSE:This is a retrospective look (08/2011-11/2014) on data collected from patients transplanted at Iowa Methodist Transplant Center.METHODS:All patients were EBV positive. They were induced with…2015 American Transplant Congress
Belatacept Treatment Through Home Infusion as a Safe and Reasonable Alternative to Intitution-Based Treatment: A Retrospective Analysis of Medical Records
1Bristol-Myers Squibb Company, Princeton, NJ; 2BiologicTx, Totowa, NJ.
Purpose: Belatacept is a selective T-cell costimulation blocker indicated for prophylaxis of organ rejection in adult patients receiving a kidney transplant in combination with basiliximab…2015 American Transplant Congress
Utility and Outcomes of Expanded Screening Among Live Solid Organ Donors
Organ Transplantation and Infectious Diseases, Northwestern University, Chicago.
Background: The Organ Procurement Transplant Network (OPTN) now requires enhanced screening of selected live donors for Trypanosoma cruzi, Strongyloides stercoralis, Tuberculosis (TB), and West Nile…
American Transplant Congress abstracts